Pardoprunox (SLV-308) hydrochloride is a partial dopamine D2 and D3 receptor partial agonist and a serotonin 5-HT1A receptor agonist, with pEC50s of 8, 9.2, and 6.3, respectively. For research use only. We do not sell to patients.
- Pardoprunox hydrochloride acts as a potent but partial D2 receptor agonist (pEC50= 8.0 and pA2=8.4) with 50% efficacy on forskolin stimulated cAMP accumulation.
- At human recombinant dopamine D3 receptors, Pardoprunox hydrochloride acts as a partial agonist (intrinsic activity of 67%; pEC50=9.2) and antagonized dopamine induction of [(35)S]GTPgammaS binding (pA2=9.0).
- Pardoprunox hydrochloride acts as a full 5-HT1A receptor agonist on forskolin induced cAMP accumulation at cloned human 5-HT1A receptors but with low potency (pEC50=6.3).